Drug intelligence / Profile preview

glycine-histidine-lysine

Development stage
Preclinical
Lead developer
Chobanian and Avedisian School of Medicine
Modality
Peptides
Administration
Topical, Inhalation
01

Overview

Glycine-histidine-lysine (GHK) is a naturally occurring human tripeptide found in plasma, urine, and saliva. It is known for its high affinity for copper(II) ions, often forming the GHK-Cu complex. GHK exhibits a wide range of biological activities, including wound healing, tissue regeneration, anti-inflammatory effects, and neuroprotection. In the context of respiratory health, research has demonstrated its ability to reverse gene expression signatures associated with emphysema and chronic obstructive pulmonary disease (COPD), promoting cellular adhesion and remodeling in lung tissue. It also shows potential in treating intracerebral hemorrhage (ICH) and neurodegenerative diseases by modulating pathways such as miR-339-5p/VEGFA and Akt/miR-146a-3p/AQP4 to alleviate neuronal apoptosis and astrocyte injury. While widely used in cosmetics and as a research tool, it is currently being investigated for therapeutic applications in chronic lung disease and neurology.

Other names
GHKGly-His-LysGlycyl-L-histidyl-L-lysineTripeptide-1Tripeptide1Tripeptide 1
02

Targets

VEGFA (Vascular endothelial growth factor A)AQP4 (Aquaporin-4)microRNA-339-5p/Vascular endothelial growth factor A axis

Beyond the preview

Go deeper on glycine-histidine-lysine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glycine-histidine-lysine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call